- Home
- PDFS vs ELVN Comparison
PDFS vs ELVN Comparison
Compare PDFS & ELVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PDFS
- ELVN
- Stock Information
- Founded
- PDFS 1992
- ELVN 2016
- Country
- PDFS United States
- ELVN United States
- Employees
- PDFS N/A
- ELVN N/A
- Industry
- PDFS EDP Services
- ELVN Biotechnology: Pharmaceutical Preparations
- Sector
- PDFS Technology
- ELVN Health Care
- Exchange
- PDFS Nasdaq
- ELVN Nasdaq
- Market Cap
- PDFS 789.4M
- ELVN 1.2B
- IPO Year
- PDFS N/A
- ELVN 2020
- Fundamental
- Price
- PDFS $23.86
- ELVN $22.68
- Analyst Decision
- PDFS Strong Buy
- ELVN Strong Buy
- Analyst Count
- PDFS 3
- ELVN 5
- Target Price
- PDFS $33.33
- ELVN $41.20
- AVG Volume (30 Days)
- PDFS 304.8K
- ELVN 571.5K
- Earning Date
- PDFS 08-07-2025
- ELVN 08-12-2025
- Dividend Yield
- PDFS N/A
- ELVN N/A
- EPS Growth
- PDFS N/A
- ELVN N/A
- EPS
- PDFS 0.03
- ELVN N/A
- Revenue
- PDFS $185,933,000.00
- ELVN N/A
- Revenue This Year
- PDFS $23.39
- ELVN N/A
- Revenue Next Year
- PDFS $18.37
- ELVN N/A
- P/E Ratio
- PDFS $797.26
- ELVN N/A
- Revenue Growth
- PDFS 11.75
- ELVN N/A
- 52 Week Low
- PDFS $15.91
- ELVN $13.30
- 52 Week High
- PDFS $37.80
- ELVN $30.03
- Technical
- Relative Strength Index (RSI)
- PDFS 66.63
- ELVN 62.96
- Support Level
- PDFS $21.95
- ELVN $21.12
- Resistance Level
- PDFS $23.66
- ELVN $23.44
- Average True Range (ATR)
- PDFS 0.82
- ELVN 1.43
- MACD
- PDFS 0.02
- ELVN 0.22
- Stochastic Oscillator
- PDFS 83.69
- ELVN 100.00
About PDFS PDF Solutions Inc.
PDF Solutions Inc offers products and services designed to empower engineers and data scientists across the semiconductor ecosystem to improve the yield, quality, and profitability of their products. The solutions combine proprietary software, physical intellectual property (or IP) for integrated circuit (or IC) designs, electrical measurement hardware tools, various methodologies, and professional services. The company's products and services are sold to integrated device manufacturers (or IDMs), fabless semiconductor companies, foundries, outsourced semiconductor assembly and test (or OSATs), and system houses.
About ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.